@article {Zhang2020.06.27.20141754, author = {Mingjiao Zhang and Lingyan Du and Oluwasijibomi Damola Faleti and Jing Huang and Gang Xiao and Xiaoming Lyu}, title = {Higher pharyngeal epithelial gene expression of Angiotensin-Converting Enzyme-2 in upper respiratory infection patients}, elocation-id = {2020.06.27.20141754}, year = {2020}, doi = {10.1101/2020.06.27.20141754}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {We analyzed the expression of ACE2 in pharyngeal epithelium and examined its relationship with clinical features and serological parameters in the upper respiratory infection (URI) patients. The expression of ACE2 were significantly higher in URI patients than in healthy controls individuals, and positively correlated with age and body temperature.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from National Natural Science Foundation of China [No. 81502335], Hong Kong Scholars Program [XJ2017-146], Natural Science Foundation of Guangdong Province [No.2020A1515010081]. Science and Technology Program of Guangzhou, China [No. 201704020127].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The recruitment process, delivery and use of clinic samples obtained from patients who had fever or routine medical examination, and the experimental procedures were approved by the Medical Ethics Committee of the Third Affiliated Hospital Of Southern Medical University, Guangzhou, China.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable.}, URL = {https://www.medrxiv.org/content/early/2020/06/29/2020.06.27.20141754}, eprint = {https://www.medrxiv.org/content/early/2020/06/29/2020.06.27.20141754.full.pdf}, journal = {medRxiv} }